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Access to indolines from primary
phenylethylamines by an unexpected palladium-
catalyzed C–H functionalization process†
Andrea Mancinelli,ac Joan Albert, bc Xavier Ariza, *ace Leon´ı A. Barrios, bd
Jordi Garcia, ace Roberto Go´mez ac and Jaume Granell *bc
A new method for the preparation of 2,2-disubstituted indolines from 2-phenylethylamines was developed
under Pd catalysis and PhI(OAc)2 as oxidant. Imines derived from 2-pyridinecarboxaldehyde were formed in
situ to direct a C–H activation process. The resulting imines were also oxidized to the corresponding amides
in the same Pd-catalyzed process to obtain the ﬁnal indoline as a picolinamide.
Introduction
The development of selective methods for the direct conversion
of carbon–hydrogen bonds into carbon–heteroatom and
carbon–carbon bonds remains a critical challenge in organic
chemistry. An interesting approach to address this issue
involves the use of substrates that contain coordinating atoms
(or directing groups) that bind to the metal center in a rst step,
and a further rearrangement allows the C–H bond activation. A
variety of transition-metal compounds have been shown to be
eﬀective in this process. Palladium complexes are particularly
attractive catalysts for such transformations because ligand-
directed C–H functionalization at palladium centres can be
used to obtain diﬀerent types of C–Y bonds (Y being carbon,
oxygen, nitrogen, sulphur, or halogen). Furthermore, palladium
can activate C–H bonds both at sp2 and sp3 sites, and a wide
range of catalytic processes have been described with diﬀerent
directing groups.1
The use of directing groups in C–H activation processes is
a strategy that provides precise site selectivity. However, it oen
involves the introduction of functional groups in the structure
of the substrates that remain in the skeleton of the products.2 A
solution to this problem can be accomplished with the use of
easily removable directing moieties.
In the last years, many eﬀorts have been addressed to the use
of transient directing groups in C–H activation.3 Among them,
we explored the use of bidentate imine-derived groups as
removable directing groups. We were interested in the func-
tionalization of phenyl groups using palladium and strong
oxidants following Sanford's works with Pd(II)/Pd(IV) catalytic
cycles.4 Our previous experience with primary amines as
directing groups in C–H functionalization reactions prompted
us to investigate the use of imines derived from 2-pyr-
idinecarboxaldehyde in acetoxylation processes (Scheme 1).5
Results and discussion
We initially tested imine 1a (Scheme 2) with several oxidants
such as NBS for bromination or trimethyluoropyridinium
tetrauoroborate for uorination but complex mixtures were
always obtained. Only when PhI(OAc)2 was used as an oxidant,
several compounds could be isolated but none of them was the
anticipated acetoxylated product. Instead, all the isolated
compounds contained an indoline framework with a new C–N
bond formed where the C–OAc bond was expected (Scheme 2).
Indoline 4 structure was unequivocally determined by X-ray
analysis (Fig. 1). The spectroscopic data of compounds 2a and
3 suggested analogous structures to compound 4.
Scheme 1 C–H functionalization directed by imines derived from 2-
pyridinecarboxaldehyde.
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The unprecedented formation of the indoline framework
involved the oxidation of an imine to an amide and an intra-
molecular C–H functionalization process but the detailed
mechanism was unclear. Remarkably, several experiments
showed that the imine derived from 2-pyridinecarboxaldehyde
was necessary. Thus, similar imines derived from benzaldehyde
or furfural, easily prepared from amine 5a by the same proce-
dure to prepare imine 1a, did not aﬀord the indoline structure
under similar conditions (Scheme 3). Furthermore, unprotected
amine 5a was just acetylated when the same process was
applied.
The C–N bond formation in aromatic compounds via Pd-
catalyzed C–H functionalization has been a topic of interest
for the last years.6 The Pd-catalyzed synthesis of indolines from
2-phenylethylamines has been reported with picolinamides,7
sulfonamides,8 1,2,3-triazole-4-carboxamides,9 oxalyl amides,10
2-(methoxyimino)amides11 and 2-(tert-butoxycarbonylamino)-
amides12 as directing groups in such C–H functionalization
processes. Based on the above preliminary results and the
importance of the indoline scaﬀold in natural and pharma-
ceutical bioactive compounds,13 we decided to explore the 2,2-
disubstituted indoline formation using imines as directing
groups. Due to the steric demand of the amino group, such
indolines are usually formed from anilines and not by C–N
bond formation as it is shown herein.13b
Synthesis of indolines from imines
The initial results encouraged us to explore diﬀerent reaction
conditions to improve the yield of indoline 2a (Table 1). An
increase of equivalents of oxidant (entries 1 and 2) improved the
yield and shortened the reaction time, being 1 hour the optimal
conditions (entries 2–4). Once it was formed, the product 2a
slowly decomposed under the reaction conditions (entries 2 and
3). A reduction of catalyst amount resulted in a drop of the yield
(entry 5), being necessary the presence of the Pd(II) catalyst to
observe the reaction (entry 6). As expected, the removal of the
oxidant was also adverse (entry 7). The amount of oxidant could
be reduced up to 1.5 equiv. of PhI(OAc)2 without a decrease of
the yield (entry 8). Reduction of the temperature to 60 !C
required longer reaction times to achieved similar yields
(entries 9 and 10). As expected, the formation of the chlorinated
indoline 3 was only observed in DCE. Reaction in other solvents
than DCE such as AcOH, acetonitrile or toluene did not aﬀord 3
and followed the same behavior but lower yields of 2a were
obtained: 20%, 40% and 50% respectively.
Synthesis of indolines from imines formed in situ
The in situ formation of imines to promote the metal-catalyzed
C–H activation has been recently used to functionalize sp2 and
sp3 C–H bonds.14
Accordingly, we next explored the possibility of the in situ
preparation of the imine followed by the indoline formation
reaction. Our rst attempt using DCE and molecular sieves for
Scheme 2 Indolines formation.
Fig. 1 Crystal structure of indoline 4. Hydrogen atoms have been
omitted for clarity. Selected bond distances (!A) and angles (!): C2–C3
¼ 1.383(5), C2–C8 ¼ 1.502(5), C8–C9 ¼ 1.538(5), C9–N1 ¼ 1.510(5),
C3–N1 ¼ 1.431(4), C10–O3 ¼ 1.232(4), C10–N1 ¼ 1.368(5), C3–C2–
C8 ¼ 110.5(3), C2–C3–N1 ¼ 108.2(3), N1–C9–C8 ¼ 101.3(3), C3–N1–
C9 ¼ 108.5(3), N1–C10–C11 ¼ 118.9(3), C2–C8– C9 ¼ 103.3(3), C3–
C2–C8 ¼ 110.5(3).
Scheme 3 Alternative nitrogen atoms as directing groups.
Table 1 Indoline 2a formation




(mol%) 3a (%) 2aa (%)
1 90 24 1 10 9 26
2 90 3 2 10 7 37
3 90 1 2 10 16 61
4 90 0.5 2 10 10 40
5 90 1 2 5 12 40
6 90 1 2 0 0 0
7 90 1 0 10 0 0
8 90 1 1.5 10 8 66
9 60 1 2 10 0 27
10 60 24 2 10 8 60
a Isolated yield.








































the imine formation and subsequent addition of 2 equiv. of
iodinane and 10 mol% of palladium acetate aﬀorded only 25%
yield of indoline 2a (Scheme 4).
Since toluene gave also good yield in the indoline formation,
we tried the two-step process in this solvent (Table 2, entry 1).
Under these conditions, an overall yield of 54% was obtained
which was comparable to the one obtained from pure imine 1a.
The palladium catalyst can be also used to accelerate the
imine formation. Thus, the time of imine formation (step 1)
could be reduced to 1 hour when the Pd(OAc)2 was added in this
step without any loss of yield (55%). The amount of 2-pyr-
idinecarboxaldehyde could also be reduced to 1 equiv. with
similar overall yield (51%).
Once we conrmed that the imine could be prepared in situ
using toluene as a solvent, we next studied the steric and elec-
tronic inuence of substituents on the phenyl ring (Table 2).
Electron donating groups in para and ortho positions aﬀor-
ded similar yields (entries 2–4) whereas an electron with-
drawing group lowered clearly the yield (entry 5).
The a-substitution of the amine is very critical. The absence
of substituents a to the amine, such in amine 5f (Fig. 2),
precluded the indoline formation. a-Monosubstituted amines
such 1-phenyl-2-propanamine (5g) or methyl phenylglycinate
(5h) did not aﬀord the expected indolines 2f–h. Furthermore,
the corresponding imines derived of 2-pyridinecarboxaldehyde
of 5f–h amines did neither aﬀorded the indolines. On the other
hand, the use of either amine 5i or the corresponding imine,
with an additional methylene group in the aliphatic chain, did
not aﬀord the expected isoquinoline type structure (2i). Thus,
we were facing to some structural limitations rather than to
problems due to the in situ formation of the imines.
However, indolines could be formed when the primary
amine was a,a-disubstituted as in compounds 5j–l, (Scheme 5).
Only, highly hindered a,a-diethyl-2-phenylethylamine aﬀorded
indoline 2l in low yield.
To gain some mechanistic insight, the reaction between
palladium acetate and imine 1a was studied (Scheme 6). When
this reaction was carried out in toluene at room temperature the
coordination compound 6 was obtained. In this complex the
imine acts as a bidentate ligand, coordinated by both nitrogen
atoms. This coordination compound experiences easily a met-
alation process. Treatment of this compound in acetic acid or
toluene for 1 h at 90 !C, produced the cyclometalated derivative
7 in good yield. Complex 8 was obtained by reaction between 7
and LiBr at room temperature in acetone.
It is also remarkable that the metalation process can even
occur in some extension in solid state. Thus, the 1H NMR
spectrum of a sample of 6, containing initially less than 2% of
cyclometalated derivative 7, shows an increase to an 8% of this
complex aer standing one week at room temperature in solid
state. It has been previously reported that palladium(II)
complexes containing two acetate ligands in the coordination
Scheme 4 In situ imine 1a formation.
Table 2 In situ indolines 2a–e formation
Entry Amine R R0 Indoline Yielda (%)
1 5a H H 2a 54
2 5b Me H 2b 49
3 5c H Me 2c 64
4 5d OMe H 2d 52
5 5e NO2 H 2e 30
a Isolated yield.
Fig. 2 Non-a,a-disubstituted amines 5f–i.
Scheme 5 a,a-Disubstitution eﬀect in indoline formation.
Scheme 6 Stoichiometric metalation of imine 1a.









































sphere are excellent starting materials to activate C–H bonds in
a facile way, and also that these compounds experience the
metalation in solid state in some extension.15
Three processes are mechanistically necessary for the indo-
line formation: (i) C–H functionalization of the phenyl ring, (ii)
imine oxidation and (iii) C–N bond formation.
To answer whether the imine oxidation or C–H functionali-
zation is the rst step of the catalytic cycle, the reaction was
performed with the imine derived of tert-butylamine (8). If the
rst step was imine oxidation, the reaction would aﬀord the
amide 9 since this imine cannot be C–H functionalized at the
phenyl group. Under the standard reaction conditions, the
structurally related imine 8 was not oxidized, and the imine was
mainly recovered (Scheme 7).
On the other hand, when the reaction was initiated in
absence of oxidant PhI(OAc)2 and, once the palladacycle 7 was
stoichiometrically formed, the oxidant was added, the indoline
was formed.16 According to the above results and based on
related processes,17 we propose a plausible mechanism based
on a Pd(II)/Pd(IV) cycle (Scheme 8).
Initial coordination of the nitrogen atoms of the imine to
Pd(OAc)2 would aﬀord complex A that can be converted to pal-
ladacycle B upon heating. In our hands, such a complex can be
formed under stoichiometric conditions in absence of oxidant.
In presence of the oxidant PhI(OAc)2, complex B would be
oxidized to a Pd(IV) complex (C). Acetate migration to the imine
carbon would aﬀord complex D.18 The cis disposition between
one acetato ligand and the NCH(AcO) fragment in this
compound permits the reduction of palladium in a process that
involves the transference of the hydrogen atom in b position to
the pendant carbonyl oxygen atom of the acetato ligand to form
acetic acid. At this point, it is important the presence of the gem-
dimethyl group, since only one hydrogen atom can be elimi-
nated, and the process can be more selective. When this group
was substituted by a methylene, a complex mixture was ob-
tained under the reaction conditions, as it was the case with the
imine derived of 2-pyridinecarboxaldehyde and the a,a-unsub-
stituted amine 5f. Pyridine-assisted deacetylation and oxidation
of complex E by an additional equivalent of PhI(OAc)2 would
form a Pd(IV) complex (F).
This complex could aﬀord two diﬀerent compounds by
reductive elimination reactions. The formation of a C–N bond
from this complex would aﬀord the corresponding indoline 2a.
In contrast the formation of a C–O (or a C–Cl bond when the
reaction was performed in DCE)19 would aﬀord an imine
derivative ortho-acetato (or ortho-chloro) substituted, which by
a sequence of metalation, oxidative addition and reductive
elimination with formation of C–N bond would aﬀord the
minor compounds 4 or 3 respectively.
It should be noted that Sanford et al. have described that the
distribution of diﬀerent compounds obtained by competitive
reductive elimination of C–Cl, C–C or C–N bonds form palla-
dium(IV) complexes is highly sensitive to the reactionmedium.20
The fact that similar imines derived from benzaldehyde or
furfural did not aﬀord the indoline structure under similar
conditions can be explained because the coordination to the
nitrogen atom of a pyridine fragment is a key point to aﬀord the
palladium(IV) derivatives. It should be noted that palladium
catalyzed oxidative synthesis of pyrrolidine, indole and indoline
derivatives needs the presence of the picolinamide fragment as
a directing group.20,21
Conclusions
In summary, a new convenient route for 2,2-disubstituted
indolines was developed via Pd-catalyzed C–H activation of
imines derived from 2-pyridinecarboxaldehyde that can be
formed in situ in one-pot synthesis from 2-phenylethylamines.
An oxidant such as PhI(OAc)2 was necessary to promote a plau-
sible Pd(II)/Pd(IV) cycle with concomitant oxidation of the imine
to an amide. The ability of the pyridine moiety to coordinate Pd
seems to be essential for this catalytic cycle. The absence of
hydrogens in the a-position of the amine is also a requirement
for the formation of indolines.
Experimental
General considerations
Amines 5f–h are commercially available. Amines 5a–e and 5j–l
were prepared according to known procedures.5a Amine 5i was
obtained from 2-methyl-4-phenylbutan-2-ol by a Ritter–Jirgen-
sons reaction.22 Elemental analysis C, H and N analyses were
performed with an Eager 1108 microanalyzer. 1H (400 MHz) and
13C (101 MHz) nuclear magnetic resonance (NMR) spectra were
registered using a Varian Mercury 400 MHz NMR spectrometer.
CDCl3 (99.9%) was used as solvent while SiMe4 (TMS) was used
as reference. The coupling constants (J) are expressed in Hz and
the chemical shis in part per million (ppm). The signals
multiplicities are reported with the following abbreviations: s
(singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and br
(broad). More complicated signals are described asScheme 7 Oxidation of imine 8.
Scheme 8 Indolines formation.









































combination of the indicated abbreviations: e.g. dd (double of
doublets), dt (double of triplets), etc. Two-dimensional experi-
ments (NOESY, HSQC) were performed to conrm the signal
assignments. ESI (+) spectra were acquired either on an LC/
MSD-TOF instrument or on a ZQ mass spectrometer, utilizing
a mixture of H2O : CH3CN (1 : 1, v/v) as the eluent. Crystallo-
graphic data for 4 were collected on a Bruker APEX II QUAZAR
diﬀractometer at the Group of Magnetism and Functional
Molecules (GMMF) of the Universitat de Barcelona, equipped
with a microfocus multilayer monochromator with Mo Ka
radiation (l ¼ 0.71073 A˚). Data reduction and absorption
corrections were performed by using SAINT23 and SADABS,23
respectively. The structure was solved using SHELXT24 and
rened with OLEX2 suite.25
General procedure for the preparation of imines
Aldehyde (6.00 mmol) was added to a solution of amine 5a
(900 mg, 6.00 mmol) in toluene (60 mL). The solution was
heated to reux overnight with a Dean–Stark apparatus. The
crude mixture was cooled to room temperature, dried with
MgSO4 and ltered. The solvent was eliminated at reduced
pressure to aﬀord the pure imine.
N-(2-Methyl-1-phenylpropan-2-yl)-1-(pyridin-2-yl)methan-imine
(1a). Brown oil, 1.43 g (6.00 mmol, 100% yield). 1H NMR (400 MHz,
CDCl3): d 8.63–8.61 (m, 1H), 8.13 (s, 1H), 8.09–8.06 (m, 1H), 7.78–
7.73 (m, 1H), 7.32–7.28 (m, 1H), 7.23–7.13 (m, 5H), 2.92 (s, 2H), 1.28
(s, 6H). 13C NMR (101 MHz, CDCl3): d 157.0, 155.4, 149.2, 138.3,
136.5, 130.7, 127.6, 126.1, 124.4, 120.8, 60.9, 49.6, 26.8. HRMS (ESI)
(m/z) calcd for [M + H]+: 239.1543, found: 239.1542.
N-(2-Methyl-1-phenylpropan-2-yl)-1-phenylmethanimine (1b).
Brown oil, 1.42 g (6.00 mmol, 100% yield). 1H NMR (400 MHz,
CDCl3): d 7.99 (s, 1H), 7.75–7.70 (m, 2H), 7.42–7.38 (m, 3H), 7.23–
7.13 (m, 5H), 2.91 (s, 2H), 1.26 (s, 6H). 13C NMR (101 MHz, CDCl3):
d 157.1, 138.1, 136.4, 131.1, 129.8, 128.9, 128.5, 127.1, 125.0, 60.9,
49.6, 26.8. HRMS (ESI) (m/z) calcd for [M + H]+: 238.1590, found:
238.1590.
1-(Furan-2-yl)-N-(2-methyl-1-phenylpropan-2-yl)methanimine (1c).
Brownoil, 1.36 g (6.00mmol, 100%yield). 1HNMR (400MHz,CDCl3):
d 7.77 (s, 1H), 7.53 (d, J¼ 1.8 Hz, 1H), 7.22–7.10 (m, 5H), 6.66 (d, J¼
3.4Hz, 1H), 6.47 (dd, J¼ 3.4, 1.8Hz, 1H), 2.91 (s, 2H), 1.24 (s, 6H). 13C
NMR (101 MHz, CDCl3): d 152.2, 145.2, 144.4, 138.2, 130.8, 127.6,
126.0, 113.7, 111.4, 60.7, 49.3, 26.8. HRMS (ESI) (m/z) calcd for [M +
H]+: 228.1383, found: 228.1383.
General procedure for the preparation of indoline 2a from
imine 1a
The imine (0.50 mmol) was dissolved in the suitable solvent (3
mL), then Pd(OAc)2 (11 mg, 0.05 mmol) and PhI(OAc)2 (322 mg,
1.00 mmol) were added. The reaction mixture was stirred at
90 !C in a sealed vial then it was ltered through a pad of Celite.
The solvent was evaporated at reduced pressure to give a crude
mixture that was puried by ash silica gel chromatography
(hexane/ethyl acetate).
(2,2-Dimethylindolin-1-yl)(pyridin-2-yl)methanone (2a). Pale
oil, 77 mg (0.31 mmol, 61%) from imine 1a in DCE for 1 h. 1H
NMR (400 MHz, CDCl3): d 8.60 (d, J ¼ 4.5 Hz, 1H), 7.86–7.81 (m,
1H), 7.66 (d, J ¼ 7.8 Hz, 1H), 7.42–7.38 (m, 1H), 7.13 (d, J ¼
7.7 Hz, 1H), 6.90–6.77 (m, 2H), 5.71 (br m, 1H), 3.05 (s, 2H), 1.70
(s, 6H). 13C NMR (101 MHz, CDCl3): d 167.2, 155.0, 149.2, 142.1,
137.2, 130.5, 126.4, 125.3, 125.2, 123.4, 123.1, 115.7, 67.5, 45.5,
25.9. HRMS (ESI) (m/z) calcd for [M + H]+: 253.1335, found:
253.1339.
(4-Chloro-2,2-dimethylindolin-1-yl)(pyridin-2-yl)methanone
(3). Pale oil, 23 mg (0.08 mmol, 16%) from imine 1a in DCE for
1 h. 1H NMR (400 MHz, CDCl3): d 8.58 (d, J ¼ 4.8 Hz, 1H), 7.88–
7.83 (m, 1H), 7.69–7.66 (m, 1H), 7.43–7.40 (m, 1H), 6.88 (d, J ¼
7.9 Hz, 1H), 6.77–6.63 (m, 1H), 5.64 (br s, 1H), 3.08 (s, 2H), 1.71
(s, 6H). 13C NMR (101 MHz, CDCl3): d 167.3, 154.4, 149.1, 143.4,
137.3, 131.0, 129.0, 127.8, 125.5, 123.5, 122.9, 114.0, 67.6, 44.5,
26.0. HRMS (ESI) (m/z) calcd for [M + H]+: 287.0951, found:
287.0950.
General procedure for the preparation of indolines from
amines
2-Pyridinecarboxaldehyde (70 mL, 0.75 mmol) was added to
a solution of amine (0.50 mmol) in dry toluene (3 mL) in the
presence of 4!A molecular sieves. The solution was stirred for 4
hours at 80 !C in a sealed vial, then Pd(OAc)2 (11 mg, 0.05
mmol) and PhI(OAc)2 (322 mg, 1 mmol) were added. The
suspension was stirred overnight at 80 !C in the sealed vial. The
crude mixture was ltered through a pad of Celite, the solvent
was eliminated at reduced pressure and the mixture was puri-
ed by ash silica gel chromatography (hexane/ethyl acetate) to
aﬀord the indoline.
Pyridin-2-yl(2,2,6-trimethylindolin-1-yl)methanone (2b). Pale
oil, 66 mg (0.25 mmol, 49%) from amine 5b (81 mg). 1H NMR
(400 MHz, CDCl3): d 8.62–8.60 (m, 1H), 7.86–7.82 (m, 1H), 7.64
(d, J ¼ 7.8 Hz, 1H), 7.43–7.39 (m, 1H), 7.01 (d, J ¼ 7.5 Hz, 1H),
6.71 (d, J ¼ 7.5 Hz, 1H), 5.51 (br s, 1H), 3.00 (s, 2H), 2.00 (s, 3H),
1.68 (s, 6H). 13C NMR (101 MHz, CDCl3): d 167.1, 155.1, 149.1,
142.2, 137.2, 136.1, 127.5, 125.0, 124.8, 123.9, 123.4, 116.7, 67.7,
45.2, 25.9, 21.6. HRMS (ESI) (m/z) calcd for [M + H]+: 267.1492,
found: 267.1491.
Pyridin-2-yl(2,2,4-trimethylindolin-1-yl)methanone (2c). Pale
oil, 85 mg (0.32 mmol, 64%) from amine 5c (81 mg). 1H NMR
(400 MHz, CDCl3): d 8.58 (d, J ¼ 4.6 Hz, 1H), 7.82–7.81 (m, 1H),
7.64 (d, J ¼ 7.8 Hz, 1H), 7.40–7.38 (m, 1H), 6.73–6.68 (m, 2H),
5.51 (br m, 1H), 2.97 (s, 2H), 2.20 (s, 3H), 1.72 (s, 6H). 13C NMR
(101 MHz, CDCl3): d 167.2, 155.0, 149.1, 141.7, 137.2, 134.6,
129.2, 126.5, 125.2, 124.1, 123.4, 113.2, 67.1, 44.3, 26.1, 18.6.
HRMS (ESI) (m/z) calcd for [M + H]+: 267.1492, found: 267.1494.
(6-Methoxy-2,2-dimethylindolin-1-yl)(pyridin-2-yl)methanone (2d).
Pale oil, 73 mg (0.26 mmol, 52%) from amine 5d (90 mg). 1H NMR
(400 MHz, CDCl3): d 8.65 (d, 1H, J ¼ 4.8 Hz), 7.86–7.82 (m, 1H), 7.65
(d, J¼ 7.8Hz, 1H), 7.42–7.38 (m, 1H), 7.01 (d, J¼ 8.2Hz, 1H), 6.44 (dd,
J ¼ 8.2, 2.2 Hz, 1H), 5.30 (br s, 1H), 3.43 (s, 3H), 2.98 (s, 2H), 1.69 (s,
6H). 13C NMR (101 MHz, CDCl3): d 167.1, 158.5, 155.0, 149.2, 143.1,
137.3, 125.4, 125.2, 123.4, 122.6, 108.9, 102.6, 68.4, 55.1, 44.8, 25.9.
HRMS (ESI) (m/z) calcd for [M + H]+: 283.1441, found: 283.1442.
(2,2-Dimethyl-6-nitroindolin-1-yl)(pyridin-2-yl)methanone
(2e). Pale oil, 35 mg (0.12 mmol, 30%) from amine 5e (75 mg).
1H NMR (400 MHz, CDCl3): d 8.60–8.56 (m, 1H), 7.98–7.94 (m,









































1H), 7.80–7.77 (m, 2H), 7.52–7.49 (m, 1H), 7.27 (d, J ¼ 7.7 Hz,
1H), 6.58 (br s, 1H), 3.13 (s, 2H), 1.72 (s, 6H). 13C NMR (101
MHz, CDCl3): d 167.4, 153.5, 149.1, 147.2, 143.3, 137.9, 137.9,
126.2, 125.2, 123.9, 118.4, 110.8, 68.8, 45.1, 25.9. HRMS (ESI) (m/
z) calcd for [M + H]+: 298.1186, found: 298.1189.
Diethyl 1-picolinoylindoline-2,2-dicarboxylate (2j). Pale oil,
39 mg (0.15 mmol, 57%) from amine 5j (50 mg). 1H NMR (400
MHz, CDCl3, 50 !C): d 8.49 (br m, 1H), 8.05 (br m, 1H), 7.87–7.82
(m, 1H), 7.40–7.35 (m, 1H), 7.15 (d, J ¼ 7.7 Hz, 1H), 7.05 (br m,
1H), 7.04–6.98 (m, 1H), 4.22–4.08 (br m, 4H), 3.74 (s, 2H), 1.34–
1.02 (br m, 6H). 13C NMR (101 MHz, CDCl3, 45 !C): d 168.1,
165.5, 152.9, 147.2, 137.2, 127.8, 127.3, 125.4, 124.2, 124.1,
116.9, 75.2, 62.0, 40.7, 13.8. HRMS (ESI) (m/z) calcd for [M + H]+:
369.1445, found: 369.1450.
Ethyl 2-methyl-1-picolinoylindoline-2-carboxylate (2k). Pale
oil, 91 mg (0.29 mmol, 59%) from amine 5k (103 mg). 1H NMR
(400 MHz, CDCl3): d 8.62 (br m, 1H), 7.83 (td, J ¼ 7.7, 1.7 Hz,
1H), 7.63 (br m, 1H), 7.42 (dd, J ¼ 7.2, 5.3 Hz, 1H), 7.14 (d, J ¼
7.7 Hz, 1H), 6.95–6.75 (m, 2H), 5.63 (br m, 1H), 4.19 (br m, 2H),
3.53 (d, J ¼ 15.7 Hz, 1H), 3.02 (d, J ¼ 15.7 Hz, 1H), 1.79 (s, 3H),
1.21 (br s, 3H). 13C NMR (101 MHz, CDCl3): d 172.5, 166.0, 153.7,
149.5, 137.3, 129.4, 127.1, 125.4, 125.2, 123.8, 123.2, 114.7, 69.7,
61.5, 41.7, 21.6, 14.1. HRMS (ESI) (m/z) calcd for [M + H]+:
311.1390, found: 311.1385.
(2,2-Diethylindolin-1-yl)(pyridin-2-yl)methanone (2l). Pale
oil, 38 mg (0.14, mmol, 27%) from amine 5l (88 mg). 1H NMR
(400 MHz, CDCl3): d 8.62 (d, 1H, J ¼ 4.6 Hz), 7.85–7.80 (m, 1H),
7.61 (d, J ¼ 7.8 Hz, 1H), 7.41–7.38 (m, 1H), 7.12 (d, J ¼ 7.3 Hz,
1H), 6.87–6.71 (m, 2H), 5.54 (br m, 1H), 3.10 (s, 2H), 2.54–2.40
(m, 2H), 1.88–1.78 (m, 2H), 0.93 (t, J¼ 7.4 Hz, 6H). 13C NMR (101
MHz, CDCl3): d 167.1, 155.0, 149.4, 143.4, 137.2, 131.0, 126.4,
125.0, 124.9, 123.1, 122.9, 114.9, 73.6, 37.9, 30.4, 8.3. HRMS
(ESI) (m/z) calcd for [M + H]+: 281.1648, found: 281.1649.
Synthesis of coordination compound 6
Palladium acetate (112 mg, 0.50 mmol) was added to a solution
of imine 1a (120 mg, 0.50 mmol) in toluene (20 mL), the
resulting solution was stirred 2 h at room temperature and then
ltered to obtain 6 as yellow crystals (135 mg, 0.32 mmol, 60%
yield). 1H NMR (400 MHz, CDCl3): d 8.42 (d, J ¼ 5.2, 1H), 8.05
(td, J ¼ 7.8, 1.5 Hz, 1H), 7.65 (d, J ¼ 7.5 Hz, 2H), 7.58–7.55 (m,
2H), 7.44 (s, 1H), 7.28 (t, J ¼ 7.5 Hz, 2H), 7.19 (t, J ¼ 7.5 Hz, 1H),
3.27 (s, 2H), 2.13 (s, 3H), 2.08 (s, 3H), 1.5 (s, 6H). MS (ESI) (m/z)
calcd for [M–2AcO]+: calcd for 344.04, found: 344.04; calcd for
[M–2AcO + CH3CN]+: 385.07, found: 385.07.
Synthesis of metalated compound 7
200mg (0.43 mmol) of 6 were dissolved in toluene and heated at
90 !C for 1 hour. The resulting solution was ltered, the solvent
was evaporated, and the residue was treated with diethyl ether
to obtain 7, as yellow crystals, 120 mg, (0.30 mmol, 70% yield).
1H NMR (400 MHz, CDCl3): d 8.60 (d, J ¼ 5.1 Hz, 1H), 8.34 (s,
1H), 7.94 (td, J ¼ 7.8, 1.6 Hz, 1H), 7.67 (d, J ¼ 7.7 Hz, 2H), 7.57
(ddd, J¼ 7.8, 5.1, 1.3 Hz, 1H), 7.35 (m, 1H), 6.92 (m, 2H), 6.79 (m
1H), 2.95 (br s, 2H), 2.15 (br s, 3H), 1.40 (br s, 6H). EA (calc. for
C18H20N2O2Pd): C: 53.4% (53.68%); H: 5.1% (5.01%); N: 6.6%
(6.95%). MS (ESI) (m/z) calcd for [M–AcO]+: 343.04, found:
343.04.
Synthesis of metalated compound 8
A mixture of 200 mg (0.50 mmol) of 7 and 130 mg of LiBr (1.50
mmol) was stirred in acetone at room temperature for 1 hour
and then ltered to obtain 8 as yellow crystals (165 mg,
0.40 mmol, 80% yield). 1H NMR (400 MHz, CDCl3): d 9.50 (d, J¼
5.5 Hz, 1H), 8.51 (s, 11H), 8.06 (dd, J ¼ 7.8, 1.2 Hz, 1H), 8.0 (td, J
¼ 7.8, 2.0 Hz, 1H), 7.74 (d, J ¼ 7.7, 1H), 7.66–7.62 (dd, J ¼ 7.8,
5.5 Hz, 1H), 6.97 (td, J¼ 7.2, 1.3 Hz, 1H), 6.90–6.85 (m, 2H), 3.15
(br s, 2H), 1.45 (br s, 6H). EA (calc. for C16H17BrN2Pd): C: 45.4%
(45.36%); H: 4.1% (4.04%); N: 6.4% (6.61%). MS (ESI) (m/z) calcd
for [M–Br]+: 343.04, found: 343.04; calcd for [M–Br + CH3CN]+:
384.07, found: 384.07.
Conﬂicts of interest
There are no conicts to declare.
Acknowledgements
This work was supported by the Generalitat de Catalunya
(2017SGR474 and 2014SGR107) and the Spanish Ministerio de
Economia y Competitividad (PGC2018-098630-B-I00, CTQ2015-
65040-P, SAF2014-52223-C2-1-R and fellowship to A. M.).
Notes and references
1 (a) T. Gensch, M. N. Hopkinson, F. Glorius and J. Wencel-
Delord, Chem. Soc. Rev., 2016, 45, 2900–2936; (b)
J. F. Hartwig, J. Am. Chem. Soc., 2016, 138, 2–24; (c)
G. Rouquet and N. Chatani, Angew. Chem., Int. Ed., 2013,
52, 11726–11743; (d) R.-Y. Zhu, M. E. Farmer, Y.-Q. Chen
and J.-Q. Yu, Angew. Chem., Int. Ed., 2016, 55, 10578–10599;
(e) Z. Chen, B. Wang, J. Zhang, W. Yu, Z. Liu and Y. Zhang,
Org. Chem. Front., 2015, 2, 1107–1295; (f) T. W. Lyons and
M. S. Sanford, Chem. Rev., 2010, 110, 1147–1169; (g)
O. Baudoin, Chem. Soc. Rev., 2011, 40, 4902–4911; (h)
A. J. Hickman and M. S. Sanford, Nature, 2012, 484, 177–
185; (i) J. Wencel-Delord, T. Droge, F. Liu and F. Glorius,
Chem. Soc. Rev., 2011, 40, 4740–4761.
2 (a) C. Sambiagio, D. Scho¨nbauer, R. Blieck, T. Dao-Huy,
G. Pototschnig, P. Schaaf, T. Wiesinger, M. F. Zia,
J. Wencel-Delord, T. Besset, B. U. W. Maes and
M. Schnu¨rch, Chem. Soc. Rev., 2018, 47, 6603–6743; (b)
Y. Li and S. Xu, Chem.–Eur. J., 2018, 24, 16218–16245; (c)
L. Ping, D. S. Chung, J. Bouﬀard and S. Lee, Chem. Soc.
Rev., 2017, 46, 4299–4328.
3 For reviews, see: (a) T. Bhattacharya, S. Pimparkar and
D. Maiti, RSC Adv., 2018, 8, 19456–19464; (b) Q. Zhao,
T. Poisson, X. Pannecoucke and T. Besset, Synthesis, 2017,
49 , 4808–4826; (c) M. R. Yadav, R. K. Rit, M. Shankar and
A. K. Sahoo, Asian J. Org. Chem., 2015, 4, 846–864; (d)
C. Wang and Y. Huang, Synlett, 2013, 24, 145–149For
recent examples, see: (e) Y. Liu and H. Ge, Nat. Chem.,









































2017, 9 , 26–32; (f) X.-Y. Chen and E. J. Sorensen, J. Am. Chem.
Soc., 2018, 140, 2789–2792.
4 S. R. Neufeldt and M. S. Sanford, Acc. Chem. Res., 2012, 45,
936–946 and references therein.
5 (a) A. Mancinelli, C. Alamillo, J. Albert, X. Ariza, H. Etxabe,
J. Farra`s, J. Garcia, J. Granell and F. J. Quijada,
Organometallics, 2017, 36, 911–919; (b) A. Rodr´ıguez,
J. Albert, X. Ariza, J. Garcia, J. Granell, J. Farra`s, A. La Mela
and E. Nicola´s, J. Org. Chem., 2014, 79 , 9578–9585; (c)
J. Albert, X. Ariza, T. Calvet, M. Font-Bardia, J. Garcia,
J. Granell, A. Lamela, B. Lo´pez, M. Martinez, L. Ortega,
A. Rodriguez and D. Santos, Organometallics, 2013, 32, 649–
659; (d) B. Lo´pez, A. Rodriguez, D. Santos, J. Albert,
X. Ariza, J. Garcia and J. Granell, Chem. Commun., 2011, 47,
1054–1056.
6 (a) Y. N. Timsina, B. F. Gupton and K. C. Ellis, ACS Catal.,
2018, 8, 5732–5776; (b) Y. Park, Y. Kim and S. Chang,
Chem. Rev., 2017, 117, 9247–9301; (c) R. K. Rit, M. Shankar
and A. K. Sahoo, Org. Biomol. Chem., 2017, 15, 1282–1293;
(d) Y. Zhou, J. Yuan, Q. Yang, Q. Xiao and Y. Peng,
ChemCatChem, 2016, 8, 2178–2192; (e) W. A. Nack and
G. Chen, Synlett, 2015, 26, 2505–2511.
7 (a) G. He, Y. Zhao, S. Zhang, C. Lu and G. Chen, J. Am. Chem.
Soc., 2012, 134, 3–6; (b) E. T. Nadres and O. Daugulis, J. Am.
Chem. Soc., 2012, 134, 7–10; (c) G. He, C. Lu, Y. Zhao,
W. A. Nack and G. Chen, Org. Lett., 2012, 14, 2944–2947.
8 (a) T.-S. Mei, D. Leow, H. Xiao, B. N. Laforteza and J.-Q. Yu,
Org. Lett., 2013, 15, 3058–3061; (b) T.-S. Mei, X. Wang and
J.-Q. Yu, J. Am. Chem. Soc., 2009, 131, 10806–10807; (c)
J.-J. Li, T.-S. Mei and J.-Q. Yu, Angew. Chem., Int. Ed., 2008,
47, 6452–6455; (d) For analogous Cu-catalyzed
functionalization, see: K. Takamatsu, K. Hirano, T. Satoh
and M. Miura, J. Org. Chem., 2015, 80, 3242–3249.
9 X. Ye, Z. He, T. Ahmed, K. Weise, N. G. Akhmedov,
J. L. Petersen and X. Shi, Chem. Sci., 2013, 4, 3712–3716.
10 C. Wang, C. Chen, J. Zhang, J. Han, Q. Wang, K. Guo, P. Liu,
M. Guan, Y. Yao and Y. Zhao, Angew. Chem., Int. Ed., 2014,
53, 9884–9888.
11 Y.-P. He, C. Zhang, M. Fan, Z. Wu and D. Ma, Org. Lett., 2015,
17, 496–499.
12 Y. Zheng, W. Song, Y. Zhu, B. Wei and L. Xuan, Org. Biomol.
Chem., 2018, 16, 2402–2405.
13 See for example: (a) D. Liu, G. Zhao and L. Xiang, Eur. J. Org.
Chem., 2010, 3975–3984and references therein. For recent
examples of 2,2-disubstituted indolines see: (b) Y. Ni,
Q. Yu, Q. Liu, H. Zuo, H.-B. Yu, W.-J. Wei, R.-Z. Liao and
F. Zhong, Org. Lett., 2018, 20, 1404–1408 and references
therein.
14 S. St John-Campbell and J. A. Bull, Org. Biomol. Chem., 2018,
16, 4582–4595.
15 H. Font, M. Font-Bardia, K. Go´mez, G. Gonza´lez, J. Granell,
I. Macho and M. Mart´ınez, Dalton Trans., 2014, 43, 13525–
13536.
16 Compared with the Pd-catalyzed reaction, these
stoichiometric conditions gave lower yield (20%).
17 (a) J. J. Topczewski andM. S. Sanford, Chem. Sci., 2015, 6, 70–
76; (b) L. V. Desai, K. J. Stowers and M. S. Sanford, J. Am.
Chem. Soc., 2008, 130, 13285–13293; (c) N. R. Deprez and
M. S. Sanford, Inorg. Chem., 2007, 46, 1924–1935.
18 Intermolecular addition of the acetate group to complex B or
C might also occur.
19 V. Botla, A. Akudari and C. Malapaka, Tetrahedron Lett.,
2019, 60, 115–119.
20 S. R. Whiteld and M. S. Sanford, J. Am. Chem. Soc., 2007,
129 , 15142–15143.
21 S. Karnakanti, Z.-L. Zang, S. Zhao, P.-L. Shao, P. Hu and
Y. He, Chem. Commun., 2017, 53, 11205–11208.
22 A. Jirgensons, V. Kauss, I. Kalvinsh andM. R. Gold, Synthesis,
2000, 1709–1712.
23 G. M. Sheldrick, SAINT and SADABS, Bruker AXS Inc.,
Madisson, Wisconsin, USA, 2012.
24 (a) G. M. Sheldrick, Acta Crystallogr., Sect. A: Found.
Crystallogr., 2008, 64, 112–122; (b) G. M. Sheldrick, SHLEXTL.
25 O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard
and H. Puschmann, J. Appl. Crystallogr., 2009, 42, 339–341.
27182 | RSC Adv., 2019, 9, 27176–27182 This journal is © The Royal Society of Chemistry 2019
RSC Advances Paper
 T
his
 ar
tic
le 
is 
lic
en
sed
 un
de
r a
 C
rea
tiv
e C
om
mo
ns
 A
ttr
ibu
tio
n-N
on
Co
mm
erc
ial
 3.
0 U
np
ort
ed
 L
ice
nc
e.
View Article Online
